Diclofenac Potassium Tablets

Diclofenac potassium is a non-steroidal anti-inflammatory analgesic derived from phenylacetic acid. Its mechanism of action is to inhibit the activity of cyclooxygenase, thereby blocking the conversion of arachidonic acid to prostaglandins. At the same time, it can also promote the combination of arachidonic acid and triglycerides, reduce the concentration of free arachidonic acid in cells, and indirectly inhibit the synthesis of leukotrienes. Diclofenac potassium is a stronger non-steroidal anti-inflammatory drug. Its inhibitory effect on prostaglandin synthesis is stronger than that of aspirin and indomethacin.

Diclofenac potassium, chemical name is [o-(2,6-dichloroaniline)]phenylacetate potassium

This product is a film-coated tablet; after removing the coating, the tablet core is white or off-white.

This product is suitable for the short-term treatment of the following acute pain: post-traumatic pain and inflammation, such as sprains, muscle strains, etc.; post-operative pain and inflammation, such as dental or orthopedic surgery, etc.; gynecological pain and inflammation, such as primary dysmenorrhea or adnexitis, etc.; pain caused by spinal syndrome; non-articular rheumatism; severe infectious pain and inflammation of the ear, nose and throat (such as tonsillitis, otitis, sinusitis, etc.), which should be treated with anti-infective drugs at the same time.

Oral administration, before meals. Adults, 100-150 mg/day; patients with mild symptoms and children over 14 years old, 75-100 mg/day, divided into 2-3 doses. For primary dysmenorrhea, the general dose is 50-150 mg/day, which can be increased to the maximum dose of 200 mg/day according to the condition, or as directed by the doctor.

1. Occasionally, there is upper abdominal pain, nausea, vomiting, diarrhea, abdominal cramps, indigestion, abdominal bloating, and anorexia. Rarely, there is gastrointestinal bleeding, hematemesis, melena, gastrointestinal ulcer, perforation, and bloody diarrhea. 2. Occasionally, there is headache, dizziness, and vertigo. Rarely, there is sleepiness. 3. Occasionally, there is rash. Rarely, there is urticaria. 4. Occasionally, there is an increase in serum aminotransferase (SGOT, SGPT), and rarely, there is hepatitis. 5. Rarely, there is an allergic reaction, such as asthma. 6. Rarely, there is edema.

1. Patients with peptic ulcers are prohibited from using this product. 2. Patients who are allergic to this product or other nonsteroidal anti-inflammatory drugs are prohibited from using this product. 3. Patients with asthma, urticaria or acute rhinitis caused by acetylsalicylic acid or other prostaglandin synthase inhibitors are prohibited from using this product.

Precautions for children: Diclofenac potassium tablets are not recommended for children and adolescents under 14 years of age. The above patients can use other forms of diclofenac preparations, such as oral drops or suppositories. This drug is also not used to treat migraine attacks in children and adolescents. Precautions for pregnancy and lactation: The use of diclofenac in pregnant women has not been studied. Therefore, diclofenac potassium is prohibited in the first six months of pregnancy unless the potential benefits to the mother outweigh the risks to the fetus. Like other non-steroidal anti-inflammatory drugs, it is prohibited in the third trimester of pregnancy because it may cause premature closure of the ductus arteriosus or uterine contraction weakness (see [Contraindications]). Animal experiments have not found any direct or indirect harmful effects on women, embryo/fetal development, delivery or postpartum development. Like other non-steroidal anti-inflammatory drugs, a small amount of diclofenac will enter lactating women. Therefore, diclofenac potassium should be avoided during lactation to avoid adverse reactions to the fetus. Fertility Like other nonsteroidal anti-inflammatory drugs, the use of diclofenac potassium may impair female fertility. Elderly patients should use the drug with caution according to the situation. Especially for frail and underweight elderly patients, the lowest effective dose should be taken.

(1) When used with alcohol or other non-steroidal anti-inflammatory drugs, gastrointestinal adverse reactions may increase, and there is a risk of ulcers. Long-term use with acetaminophen may increase the toxic side effects on the kidneys. (2) When used with anticoagulants such as heparin and dicoumarol and platelet aggregation inhibitors, there is an increased risk of bleeding. (3) When used with potassium-sparing diuretics, it may cause hyperkalemia. (4) When used with verapamil and nifedipine, the blood concentration of this product increases. (5) This product can increase the blood concentration of digoxin and lithium preparations. When used together, it is necessary to pay attention to adjusting the dose of digoxin and lithium preparations. (6) When used together with antidiabetic drugs, this product may affect the efficacy of the latter, so it needs to be considered carefully. (7) When used together with antihypertensive drugs, this product may affect the antihypertensive effect of the latter. (8) This product can reduce the excretion of methotrexate and increase its blood concentration, even to toxic levels, so this product should not be used with medium or large doses of methotrexate. (9) When this product is used in combination with cyclosporine, it can increase the toxicity of the latter.

Keep tightly closed in a dry place.

25mg

24 months

Tai Chi Group Sichuan Mianyang Pharmaceutical Co., Ltd.

• Founded in:

  1998-12-31

• Address:

  No. 278, Jiannan Road, Mianyang City, Sichuan Province

• Tax NO.:

  915107042054192198

• Registered Funds:

  20 million yuan

• Website:

  Log in to view

• Email:

  Log in to view